Finch Therapeutics Group Inc (FNCH)
2.30
-0.19
(-7.63%)
USD |
NASDAQ |
May 03, 16:00
2.36
+0.06
(+2.61%)
After-Hours: 20:00
Finch Therapeutics Group Accounts Receivable (Quarterly): 0.00 for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.107M |
| December 31, 2022 | 0.144M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.174M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.172M |
| December 31, 2021 | 0.494M |
| September 30, 2021 | 2.399M |
| June 30, 2021 | 2.245M |
| March 31, 2021 | 2.251M |
| December 31, 2020 | 1.034M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
2.399M
Maximum
Sep 2021
0.6938M
Average
0.172M
Median
Mar 2022
Accounts Receivable (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 98.27M |
| Vanda Pharmaceuticals Inc | 34.16M |
| Sage Therapeutics Inc | -- |
| BioSig Technologies Inc | 0.024M |
| Palisade Bio Inc | -- |